[1]
“CYP2C9 and VKORC1-1639 genetic polymorphisms involved in warfarin pharmacogenetics and pharmacodynamics in Latin American population”, torreon, vol. 10, no. 27, pp. 76–91, Feb. 2021, doi: 10.5377/torreon.v10i27.10842.